| Literature DB >> 28183261 |
Giuseppina Laganá1, Davide Barreca1, Antonella Calderaro1, Ersilia Bellocco1.
Abstract
Lactate dehydrogenase (LHD) is a key enzyme of anaerobic metabolism in almost all living organisms and it is also a functional checkpoint for glucose restoration during gluconeogenesis and single-stranded DNA metabolism. This enzyme has a well preserved structure during evolution and among the species, with little, but sometimes very useful, changes in the amino acid sequence, which makes it an attractive target for the design and construction of functional molecules able to modulate its catalytic potential and expression. Research has focused mainly on the selection of modulator especially as far as LDH isozymes (especially LDH-5) and lactate dehydrogenases of Plasmodium falciparum (pfLDH) are concerned. This review summarizes the recent advances in the design and development of inhibitors, pointing out their specificity and therapeutic potentials. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Lactate dehydrogenase; bifunctional inhibitors; enzyme inhibitors; galloflavin; miRNA and shRNAs; oxamate and derivatives; quinoline derivatives.
Mesh:
Substances:
Year: 2019 PMID: 28183261 DOI: 10.2174/0929867324666170209103444
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530